Skip to Main Content (Press Enter)

Logo CNR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNI-FIND
Logo CNR

|

UNI-FIND

cnr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Isoniazid-induced inhibition of GABAergic transmission enhances neurosteroid content in the rat brain

Academic Article
Publication Date:
1996
abstract:
Isoniazid (375 mg/kg, s.c.), a drug that decreases GABA(A) receptor-mediated transmission, elicited a time-dependent increase of neuroactive steroid (pregnenolone, progesterone and allotetrahydro-deoxycorticosterone) concentrations in rat brain and plasma. This treatment also time-dependently increased the plasma concentration of corticosterone. Brain and plasma neuroactive steroid levels peaked between 40 and 120 min after isoniazid administration, respectively, and returned to control values by 5 hr. Acute foot shock stress mimicked the effect of isoniazid by increasing in a time-dependent manner the same neuroactive steroids both in brain and plasma. Abecarnil (0.3 mg/kg, i.p.), a beta-carboline derivative with anxiolytic properties, antagonized the effect of both isoniazid and foot shock on brain and plasma neuroactive steroids and on plasma corticosterone level. These data indicate that an inhibition of central GABAergic transmission enhances the concentrations of THDOC and its precursors pregnenolone and progesterone in the rat brain and plasma as well as the plasma levels of corticosterone. This finding suggests that GABA exerts a tonic inhibitory action on the mechanisms involved in the regulation of the synthesis and release of these neuroactive steroids in the central nervous system and plasma. Copyright (C) 1996 Elsevier Science Ltd.
Iris type:
01.01 Articolo in rivista
Keywords:
isoniazid; stress; GABA; neurosteroids; brain; plasma; rat
List of contributors:
Mostallino, MARIA CRISTINA
Authors of the University:
MOSTALLINO MARIA CRISTINA
Handle:
https://iris.cnr.it/handle/20.500.14243/288569
Published in:
NEUROPHARMACOLOGY
Journal
  • Overview

Overview

URL

http://www.sciencedirect.com
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.0.0 | Sorgente dati: PREPROD (Ribaltamento disabilitato)